Clinical Trial Update: ENT FiberLase CO2 Study [NA]

View source ↗

Summary

The ENT FiberLase CO2 study sponsored by Lumenis Be Ltd. in laryngeal and pharyngeal diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Diseases
• Pharyngeal Diseases

Snippet

Sponsor: Lumenis Be Ltd. | Conditions: Laryngeal Diseases, Pharyngeal Diseases | NA | Status: COMPLETED